Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-05 2024-06-07 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-01-30 230958
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-06-20 2025-02-06 230961
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-07-11 2025-02-20 232747
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-23 2025-03-04 248445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-03-27 250909
TEVA-BUSPIRONE 10MG TABLET Resolved 2024-04-25 2025-03-13 226174

Showing 881 to 900 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TENOFOVIR 300MG TABLET Discontinued 2025-04-29 2025-04-29 256088
TEVA-TOPISONE 0.05% LOTION Discontinued 2024-06-28 2024-06-29 231589
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256104
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIAMTERENE/HCTZ 25MG 50MG TABLET Discontinued 2017-06-27 2017-06-27 14060
TEVA-TRIAMTERENE/HCTZ 50MG 25MG TABLET Discontinued 2020-05-14 2020-05-14 115091
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2018-10-19 2018-10-19 65017

Showing 261 to 280 of 299